OGN -.05 to 14.60 after missing estimates, but the stock is very cheap based on non-GAAP EPS ..... however there is a huge difference between GAAP and non-GAAP -
Your thoughts on the quarter ?
briefing -
Organon misses by $0.18, misses on revs; lowers FY23 revs below consensus (14.65 ) :
Reports Q3 (Sep) earnings of $0.87 per share, excluding non-recurring items, $0.18 worse than the FactSet Consensus of $1.05; revenues fell 1.2% year/year to $1.52 bln vs the $1.57 bln FactSet Consensus. Co issues lowered guidance for FY23, sees FY23 revs of $6.15-6.25 bln from $6.25-6.45 bln vs. $6.31 bln FactSet Consensus.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.